Pursuant to Regulations 30 and 34 of the SEBI (LODR) Regulations, 2015, as amended ('''' Listing Regulations''''), please find attached herewith the Annual Report of the Company for the FY 2025-26 along with Notice convening the 20th Annual General Meeting ("AGM") of the Company on Wednesday, 30th September, 2026 at 12 :00 Noon. (IST) through Video Conferencing (VC) / Other Audio Visual Means (OA VM).

CIN No:- L24230PB2006PLC030341 Department of Corporate Services BSE Limited, P J Towers, Dalal Street, Mumbai - 400001 Ref: BSE Security Code 540694. SSub:u bmiof Asnnusal Rieporot forn the Financial Year 2025-26, Dear Sir/Madani, Pursuant to Regulation 34(1) of SEB! (Listing Obligations and Disclosure Requirements) Regulations, 2015, Please find enclosed herewith copy of Annual Report for the financial year 2025-26 along with notice convening the 20" Annual General Meeting of the members of the company. The same has been displayed on the website of the company www.anglifesciences.com. Kindly acknowlthee rdecgeiept of the same. For ANG Lifesciences India Limited @QANnc Lifesciences O 2025-2026 O ANG LIFESCIENCES INDIA LIMITED SCO 113 Darbara Complex, 1st Floor, B Block Ranjit Avenue Amritsar, 143001. www.anglifesciences.com | cs@anglifesciences.com Lh a & & Aa ANNUAL REPORT 2025-2026 Corporate Information 'B oard of Directors | Bankers Mr, Rajesh Gupta _| Managing Director | Punjab National Bank Mrs. Saruchi Gupta | Whole time Director | HDFC Bank Mr. Rohit Mittal Non-Executive Director Canara Bank Mr. Sukhpal Singh _| Independent Director Mr. Harvinder Singh | Independent Director ET. Mr. Chetna Independent Director Wholly Owned Subsidiary Mansa Print & Publishers Limited Chief Financial Officer | Mrs. Saruchi Gupta | Company Secretary | rndex Ms. Harshita Aggarwal Notice of AGM and Notes 1 Darbara Complex, SCO-113, First Floor, District Annexure of Board's Report Shopping Complex, B-Block, Ranjit Avenue, 21 Amritsar Corporate Governance Report 143001 Tel. Ph. No. 0183-5133455, 5133473 30 | Statutory Auditor | MP & CFO Gertiication 43 Ms Khurana Sharma & Company, Management Discussion Report “ H..No. 1299, Sector 15:8, Chandigam Standalone Financial Statement 4g Secretarial Auditor | Consolidated Financial Statement 166 Anil Negi & Company Shiwalik Bhawan Near Hotel Osheen, Tara Hall Shimla, Himachal Pradesh 171002 Registrar & Share Transfer Agent Bigshare Services Private Limited, E-2/3 Ansa Industrial Estate, Sakivihar Road, Sakinaka, Andheri(East), Mumbai-400072 ANNUAL REPORT 2025-2026 NOTICE OF 20" ANNUAL GENERAL MEETING Notice is hereby given that 20" Annual General Meeting of the members of ANG Lifesciences India Limited will be held on Wednesday, 30" day of September 2026 at 12:00 A.M. through video conferencing/other audio video visual means to transact the following business: ORDINARY BUSINESS 1. To receive, consider and adopt the Audited Standalone Financial Statements of the Company for the financial year ended 31° March, 2026 and the reports of the Board of Directors and Auditors thereon. 2, To receive, consider and adopt the Audited Consolidated Financial Statements of the company for the financial year ended 31° March, 2026 together with the reports of Auditors thereon. 3. To appoint a director in place of Mr. Rohit Mittal (DIN: 10349180), who retires by rotation and being eligible, offers him-self for re-appointment. “RESOLVED THAT Mr. Rohit Mittal (DIN: 10349180), who retires by rotation and being eligible, offers himself for re-appointment be and is hereby appointed as a Director of the Company, liable to retire by rotation,” SPECIAL BUSINESS 4. Ratification of the Cost Auditor Remuneration for the financial year 2026-27: To consider and if thought fit, pass with or without modifications(s), the following resolution as an Ordinary Resolution: “RESOLVED THAT pursuant to the provisions of section 148 and other applicable provisions, if any, of the Companies Act, 2013 (the “Act”) (including any statutory modifications or re-enactment thereof) read with rules framed thereunder, the appointment of M/s Shreya Sahu & Associates (FRN 101389) as Cost auditor of the Company, for conducting the Cost Audit for the financial year 2026-27 and payment of remuneration of Rs. 80,000/- (Rupees Eighty Thousand Only) per annum plus applicable taxes thereon and re- imbursement of oul-of-pocket expenses incurred by them in connection with the aforesaid audit, as approved by the Board of Directors of the Company on the recommendation of the Audit Committee, be and is hereby ratified and confirmed RESOLVED FURTHER THAT the Board of Directors or a Committee thereof be and is hereby authorized to do all such acts, deeds, matters and things as it may it its absolute discretion consider necessary or expedient to give effect to the aforesaid resolution.” 5. Re- appointment of Mrs. Chetna (DIN: 08981045) as an Independent Director of the company: To consider and if thought fit, pass with or without modification(s) the following resolutions as Special Resolution: “RESOLVED THAT pursuant to the provisions of Sections 149, 150 and 152 and other applicable provisions, if any, read along with Schedule IV to the Companies Act, 2013 (‘the Act’), the Companies (Appointment and Qualifications of Directors) Rules, 2014 [including any statutory modification(s) or re- enactment(s) thereof for the time being in force] and Regulation 17 and any other applicable provisions of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘SEBI Listing Regulations’), as amended from time to time, Mrs. Chetna (DIN: 08981045), who was appointed as an Independent Director of the Company for a term of five (5) consecutive years commencing from October 12, 2021 to October 11, 2026 (both days inclusive) and who being eligible for re- appointment as an Independent Director has given her consent along with a declaration that she meets the criteria for independence under Section 149(6) of the Act and the Rules framed thereunder and Regulation 16(1)(b) of the SEBI Listing Regulations and in respect of whom the Company has received a Notice in ANNUAL REPORT 2025-2026 writing from a Member under Section 160(1) of the Act proposing her candidature for the office of Director and based on the recommendation of the Nomination & Remuneration Committee and the Board of Directors of the Company, be and is hereby re-appointed as an Independent Director of the Company, not liable to retire by rotation, to hold office for a second term of five (5) consecutive years commencing from October 12, 2026 to October 11, 2031 (both days inclusive). RESOLVED FURTHER THAT the Board of Directors of the Company (including its Committee thereof) be and is hereby authorized to do all such acts, deeds, matters and things as may be necessary, expedient and desirable for the purpose of giving effect to this resolution.” By and order of the Board of Directors For ANG Lifesciences India Limited Sdi- Date: 07.09.2026 Harshita Aggarwal Place: Amritsar Company Secretary Notes 1 Pursuant to the General Circular No. 03/2025 dated September 22, 2025, issued by the Ministry of Corporate Affairs (MCA) and other applicable circulars and notifications issued (including any statutory modifications or re-enactment thereof for the time being in force and as amended from time to time, companies are allowed to hold AGM through Video Conferencing (VC) or other audio visual means (OAVM), without the physical presence of members at a common venue. In compliance with the said Circulars, 20" AGM shall be conducted through VC / OAVM. 2. Pursuant to the Circular No. 14/2020 dated April 08, 2020, issued by the Ministry of Corporate Affairs, the facility to appoint proxy to attend and cast vote for the members is not available for this AGM. However, the Body Corporates are entitled to appoint authorized representatives to attend the AGM through VC/OAVM and participate there at and cast their votes through e-voting. 3, The Members can join the AGM in the VC/OAVM mode 15 minutes before and after the scheduled time of the commencement of the Meeting by following the procedure mentioned in the Notice, The facility of participation at the AGM through VC/OAVM will be made available for 1000 members on first come first served basis. This will not include large Shareholders (Shareholders holding [Showing first 8,000 characters — download PDF for full document]